Skip to main content

Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA

  • Protocol
Nucleic Acid Aptamers

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1380))

Abstract

Aptamers selected against cell surface receptors represent a unique set of ligands that can be used to target nanoparticles and other therapeutics to specific cell types. Here, we describe a method for using aptamers to deliver stable nucleic acid lipid particles (SNALPs) encapsulating small interfering RNA (siRNA) to cells in vitro. Using this method, we have demonstrated the ability of aptamer-conjugated SNALPs to achieve target-specific delivery and siRNA-mediated knockdown of a gene of interest. We also describe methods to characterize SNALP size, siRNA encapsulation efficiency, and aptamer conjugation efficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Semple SC, Akinc A, Chen J et al (2010) Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28:172–176

    Article  CAS  PubMed  Google Scholar 

  2. Heyes J, Palmer L, Bremner K et al (2005) Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J Control Release 107:276–287

    Article  CAS  PubMed  Google Scholar 

  3. Heyes J, Hall K, Tailor V et al (2006) Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. J Control Release 112:280–290

    Article  CAS  PubMed  Google Scholar 

  4. Lammers T, Kiessling F, Hennink WE et al (2011) Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release

    Google Scholar 

  5. Davis ME, Zuckerman JE, Choi CHJ et al (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464:1067–1070

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Davis ME (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6:659–668

    Article  CAS  PubMed  Google Scholar 

  7. Akinc A, Querbes W, De S et al (2010) Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther 18:1357–1364

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Sato Y, Murase K, Kato J et al (2008) Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 26:431–442

    Article  CAS  PubMed  Google Scholar 

  9. Tam Y, Chen S, Cullis P (2013) Advances in lipid nanoparticles for siRNA delivery. Pharmaceutics 5:498–507

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Tam YYC, Chen S, Zaifman J et al (2013) Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA. Nanomedicine 9:665–674

    Article  CAS  PubMed  Google Scholar 

  11. Wilner SE, Wengerter B, Maier K et al (2012) An RNA alternative to human transferrin: a new tool for targeting human cells. Mol Ther Nucleic Acids 1, e21

    Article  PubMed Central  PubMed  Google Scholar 

  12. Ni X, Zhang Y, Ribas J et al (2011) Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. J Clin Invest 121:2383–2390

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Zhou J, Swiderski P, Li H et al (2009) Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells. Nucleic Acids Res 37:3094–3109

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Dhar S, Gu FX, Langer R et al (2008) Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci 105:17356–17361

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Zhou J, Rossi JJ (2014) Cell-type-specific, aptamer-functionalized agents for targeted disease therapy. Mol Ther Nucleic Acids 3, e169

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Reulen SWA, Brusselaars WWT, Langereis S et al (2007) Protein-liposome conjugates using cysteine-lipids and native chemical ligation. Bioconjug Chem 18:590–596

    Article  CAS  PubMed  Google Scholar 

  17. Leung AKK, Hafez IM, Baoukina S et al (2012) Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core. J Phys Chem C 116:18440–18450

    Article  CAS  Google Scholar 

  18. Jayaraman M, Ansell SM, Mui BL (2012) Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed 51(34):8529–8533

    Article  CAS  Google Scholar 

  19. Jeffs LB, Palmer LR, Ambegia EG et al (2005) A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharm Res 22:362–372

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew Levy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Wilner, S.E., Levy, M. (2016). Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA. In: Mayer, G. (eds) Nucleic Acid Aptamers. Methods in Molecular Biology, vol 1380. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3197-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3197-2_18

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3196-5

  • Online ISBN: 978-1-4939-3197-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics